Burden of Asthma and Role of 2.5 µg Tiotropium Respimat® as an Add-On Therapy: A Systematic Review of Phase 2/3 Trials-Reference-Cited by-同舟云学术

Burden of Asthma and Role of 2.5 µg Tiotropium Respimat® as an Add-On Therapy: A Systematic Review of Phase 2/3 Trials

Published:2019-08-21 Issue:10 Volume:36 Page:2587-2599
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Mansfield Lyndon,Duong-Quy Sy,Craig Timothy

Funder

Boehringer Ingelheim

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-019-01062-w.pdf

Reference42 articles.

1. Centers for Disease Control and Prevention. National current asthma prevalence. 2016. https://www.cdc.gov/asthma/most_recent_data.htm . Accessed Mar 8, 2019.

2. Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008–2013. Ann Am Thorac Soc. 2018;15(3):348–56.

3. Carr TF, Bleecker E. Asthma heterogeneity and severity. World Allergy Organ J. 2016;9(1):41.

4. Wark PA, Gibson PG. Asthma exacerbations. 3: Pathogenesis. Thorax. 2006;61(10):909–15.

5. Mathur SK, Viswanathan RK. Relevance of allergy in adult asthma. Curr Allergy Asthma Rep. 2014;14(5):437.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance Therapy for Children and Adolescents with Asthma: Guidelines and Recommendations from the Emilia-Romagna Asthma (ERA) Study Group;Journal of Clinical Medicine;2023-08-23

2. The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2023-08-01

3. New perspectives on the role of muscarinic antagonists in asthma therapy;Expert Review of Respiratory Medicine;2020-04-26